For sales

Highlights from the Week of 13th July – 20th July in the world of pharma and healthcare!

Highlights from the Week of 13th July 2026 - 20th July 2026 ( FDA, Approval ) FDA approves Biogen's sBLA for once-weekly LEQEMBI IQLIK SC as an initiation dose to treat early Alzheimer's disease ( FDA, Approval ) FDA grants traditional approval to Novartis' FABHALTA, that slows kidney function decline in adults with IgAN ( FDA, Approval ) Merck receives FDA approval for LIPFENDRA tablets 20 mg as an adjunct to diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including HeFH ( FDA, Approval ) Celcuity obtains FDA approval for REVTORPYK to treat HR+, HER2- locally advanced or metastatic breast cancer Pg 1/4 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.